157 related articles for article (PubMed ID: 17164594)
1. Effects of pH on du intake and removal by CBMIDA and EHBP.
Fukuda S; Ikeda M; Nakamura M; Yan X; Xie Y
Health Phys; 2007 Jan; 92(1):10-4. PubMed ID: 17164594
[TBL] [Abstract][Full Text] [Related]
2. Acute toxicity of subcutaneously administered depleted uranium and the effects of CBMIDA in the simulated wounds of rats.
Fukuda S; Ikeda M; Nakamura M; Yan X; Xie Y
Health Phys; 2009 Apr; 96(4):483-92. PubMed ID: 19276709
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of uranium and the removal effects of CBMIDA and EHBP in simulated wounds of rats.
Fukuda S; Iida H; Ikeda M; Yan X; Xie Y
Health Phys; 2005 Jul; 89(1):81-8. PubMed ID: 15951694
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of oral and intraperitoneal administration of CBMIDA for removing uranium in rats after parenteral injections of depleted uranium.
Fukuda S; Ikeda M; Nakamura M; Yan X; Xie Y
Radiat Prot Dosimetry; 2009 Jan; 133(1):12-9. PubMed ID: 19168864
[TBL] [Abstract][Full Text] [Related]
5. The effects of bicarbonate and its combination with chelating agents used for the removal of depleted uranium in rats.
Fukuda S; Ikeda M; Nakamura M; Katoh A; Yan X; Xie Y; Kontoghiorghes GJ
Hemoglobin; 2008; 32(1-2):191-8. PubMed ID: 18274996
[TBL] [Abstract][Full Text] [Related]
6. Inositol hexaphosphate: a potential chelating agent for uranium.
Cebrian D; Tapia A; Real A; Morcillo MA
Radiat Prot Dosimetry; 2007; 127(1-4):477-9. PubMed ID: 17627956
[TBL] [Abstract][Full Text] [Related]
7. Clinical diagnostic indicators of renal and bone damage in rats intramuscularly injected with depleted uranium.
Fukuda S; Ikeda M; Chiba M; Kaneko K
Radiat Prot Dosimetry; 2006; 118(3):307-14. PubMed ID: 16436523
[TBL] [Abstract][Full Text] [Related]
8. Radiation protection by deferiprone in animal models.
Fukuda S; Ikeda M; Anzai K; Suzuki M; Katoh A; Kontoghiorghes GJ
Hemoglobin; 2006; 30(2):201-8. PubMed ID: 16798644
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ethane-1-hydroxy-1,1-bisphosphonate (EHBP) for the decorporation of uranium after intramuscular contamination in rats.
Henge-Napoli MH; Ansoborlo E; Chazel V; Houpert P; Paquet F; Gourmelon P
Int J Radiat Biol; 1999 Nov; 75(11):1473-7. PubMed ID: 10597920
[TBL] [Abstract][Full Text] [Related]
10. Chelating agents used for plutonium and uranium removal in radiation emergency medicine.
Fukuda S
Curr Med Chem; 2005; 12(23):2765-70. PubMed ID: 16305471
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of implanted depleted uranium (DU) on adult rat behavior and toxicological endpoints.
Arfsten DP; Wilfong ER; Bekkedal MY; Johnson EW; McInturf SM; Eggers JS; Schaeffer DJ; Still KR
J Toxicol Environ Health A; 2007 Dec; 70(23):1995-2010. PubMed ID: 17966071
[TBL] [Abstract][Full Text] [Related]
12. Orally administered ethane-1-hydroxy-1,1-biphosphonate reduces the lethal effect of oral uranium poisoning.
Martínez AB; Cabrini RL; Ubios AM
Health Phys; 2000 Jun; 78(6):668-71. PubMed ID: 10832926
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical evaluation of 2,3-dimercaptosuccinic acid as a radiation nephrotoxicity protective agent during radiopeptide therapy of neuroendocrine malignancy.
Moorin RE; Meyrick DP; Rose A
Nucl Med Commun; 2007 Apr; 28(4):261-6. PubMed ID: 17325588
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of ion-imprinted chitooligosaccharides as uranium-specific chelating agents against the cytotoxicity of depleted uranium in human kidney cells.
Zhang XF; Ding CL; Liu H; Liu LH; Zhao CQ
Toxicology; 2011 Aug; 286(1-3):75-84. PubMed ID: 21645583
[TBL] [Abstract][Full Text] [Related]
15. Renal dysfunction induced by long-term exposure to depleted uranium in rats.
Zhu G; Xiang X; Chen X; Wang L; Hu H; Weng S
Arch Toxicol; 2009 Jan; 83(1):37-46. PubMed ID: 18594794
[TBL] [Abstract][Full Text] [Related]
16. Effect of catecholamic acid on detoxication and distribution of NiCl2 in mice and rats.
Yan XM; Tao ZQ; Liang YY; Chen ZJ; Zhang JS; Xu XH
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):80-4. PubMed ID: 10375767
[TBL] [Abstract][Full Text] [Related]
17. Effect of biphosphonates on abnormal mandibular growth of rats intoxicated with uranium.
Ubios AM; Braun EM; Cabrini RL
Health Phys; 1998 Dec; 75(6):610-3. PubMed ID: 9827507
[TBL] [Abstract][Full Text] [Related]
18. Effect of ethane-1-hydroxy-1,1-bisphosphonate (EHBP) on endochondral ossification lesions induced by a lethal oral dose of uranyl nitrate.
Bozal CB; Martinez AB; Cabrini RL; Ubios AM
Arch Toxicol; 2005 Aug; 79(8):475-81. PubMed ID: 15798912
[TBL] [Abstract][Full Text] [Related]
19. Effects of chelating agents on tissue distribution and excretion of nickel in mice.
Xie J; Funakoshi T; Shimada H; Kojima S
Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):245-55. PubMed ID: 7881873
[TBL] [Abstract][Full Text] [Related]
20. Renal function in mice poisoned with oral uranium and treated with ethane-1-hydroxy-1,1-bisphosphonate (EHBP).
Martinez AB; Mandalunis PM; Bozal CB; Cabrini RL; Ubios AM
Health Phys; 2003 Sep; 85(3):343-7. PubMed ID: 12938724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
